13
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Crohn Disease Arthropathy: Antigens in Synovial Fluid Share Epitopes with Strains of Two Species of Viridans Streptococci

Pages 287-292 | Published online: 08 Jul 2009

References

  • References
  • Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis: a pathologic and clinical entity. JAMA 1932;99:1323–9.
  • Sartor RB. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn’s disease. Gastroenterol Clin North Am 1995;24:475–507.
  • Hadden JW, Smithyman AM, Warfel AH. Mechanisms of granuloma formation. In: Safai B, Good RA, editors. Comprehensive immunology. 7. Immuno-dermatology. London: Plenum; 1981. p. 449–65.
  • Janowitz HD, Croen EC, Sachar DB. The role of the fecal stream in Crohn’s disease: an historical and analytical review. Inflamm Bowel Dis 1988;4:29–39.
  • Harper PH, Lee ECG, Kettlewell MGW, Jewell DP. Role of the faecal stream in the maintenance of Crohn’s colitis. Gut 1985; 26:279–84.
  • Morson BC. Pathology of Crohn’s disease. Clin Gastroenterol 1972;1:265–77.
  • Rickert RR, Carter HW. The ‘early’ ulcerative lesions of Crohn’s disease: correlative light- and scanning electron- microscopic studies. J Clin Gastroenterol 1980;2:11–9.
  • Owen RL, Jones AL. Epithelial cell specialization within human Peyer’s patches: an ultrastructural study of intestinal lymphoid follicles. Gastroenterology 1974;66:189–203.
  • Jacob E, Baker SJ, Swaminathan SP. ‘M’ cells in the follicle- associated epithelium of the human colon. Histopathology 1987;11:941–52.
  • Gorbach SL. Intestinal microflora. Gastroenterology 1971;60:1110–29.
  • Lahesmaa-Rantala R, Granfors K, Isomaki H, Toivanen A. Yersinia specific immune complexes in the synovial fluid of patients with yersinia triggered reactive arthritis. Ann Rheum Dis 1987;46:510–4.
  • Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn’s disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976;55: 401–12.
  • Hannestad K. Presence of aggregated tG-globulin in certain rheumatoid synovial effusions. Clin Exp Immunol 1967;2:511–29.
  • Creighton WD, Lambert PH, Miescher PA. Detection of antibodies and soluble antigen-antibody complexes by precipitation with polyethylene glycol. J Immunol 1973;111:1219–27.
  • Affinity chromatography: principles and methods. Lund, Sweden: Pharmacia Fine Chemicals; 1974.
  • Bank RA, Hettama EH, Arwert F, Amerongen AVN, Pronk JC. Electrophoretic characterization of posttranslational modifications of human parotid salivary α-amylase. Electrophoresis 1991;12:74–9.
  • Laemmli UK. Cleavage of structural proteins during the assembly ofthe head bacteriophage T4. Nature 1970;277:680–5.
  • Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350–4.
  • Dunbar BS Two dimensional electrophoresis and immunological techniques. New York: Plenum; 1987.
  • Beighton D, Hardie JM, Whiley RA. A scheme for the identification of viridans streptococci. J Med Microbiol 1991;35:367–72.
  • Tabaqchali S, O’Donoghue DP, Bettelheim KA. Escherichia coli antibodies in patients with inflammatory bowel disease. Gut 1978;19:108–13.
  • Matthews N, Mayberry JF, Rhodes J, Neale L, Munro J, Wensinck F, et al. Agglutinins to bacteria in Crohn’s disease. Gut 1980;21:376–80.
  • Blaser MJ, Miller RA, Lacher J, Singleton JW. Patients with active Crohn’s disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology 1984;87:888–94.
  • Olaison G. Abnormal intestinal permeability in Crohn’s disease. Scand J Gastroenterol 1990;25:321–8.
  • Cartun RW, van Kruiningen HJ, Pederson CA, Berman MM. An immunocytochemical search for infectious agents in Crohn’s disease. Mod Pathol 1993;6:212–9.
  • Liu Y, van Kruiningen HJ, West AB, Cartun RW, Cortot A, Colombel JF. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn’s disease. Gastroenterology 1995;108:1396–404.
  • Tappuni AR, Challacombe SJ. Distribution and isolation frequency of eight streptococcal species in saliva from predentate and dentate children and adults. J Dent Res 1993;72:31–6.
  • Pearce C, Bowden GH, Evans M, Fitzsimmons SP, Johnson J, Sheridan MJ, et al. Identification of pioneer viridans streptococci in the oral cavity of human neonates. J Med Microbiol 1995;42:67–72.
  • Peach S, Lock MR, Katz D, Todd IP, Tabaqchali S. Mucosal- associated bacterial flora ofthe intestine in patients with Crohn’s disease and in a control group. Gut 1978;19:1034–42.
  • Forcione DG, Sands B, Isselbacher KJ, Rustgi A, Podolsky DK, Pillai S. An increased risk of Crohn’s disease in individuals who inherit the HLA class II DRB3*0301 allele. Proc Natl Acad Sci USA 1996;93:5094–8.
  • Lopez-Cubero SO, Sullivan KM, McDonald GB. Course of Crohn’s disease after allogenic marrow transplantation. Gastroenterology 1998;114:433–40.
  • Kashyap P, Forman SJ. Autologous bone marrow transplantation for non-Hodgkins lymphoma resulting in long-term remission of coincidental Crohn’s disease. Br J Haematol 1998;103:651–2.
  • Mowat AM. Oral tolerance and regulation of immunity to dietary antigens. In: Ogra PL, editor. Handbook of mucosal immunology. San Diego (CA): Academic Press; 1994. p. 185–201.
  • Gent AE, Hellier MD, Grace RH, Swarbrick ET, Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994;343:766–7.
  • Camoglio L, Te Velde AA, Tiggs AJ, Das PK, Van Deventer SJH. Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease. Inflamm Bowel Dis 1988;4:285–90.
  • Moss AA, Carbone JV, Kressel HY. Radiological and clinical assessment of broad-spectrum antibiotic therapy in Crohn’s disease. Am J Roentgenol 1978;131:787–90.
  • Peppercorn MA. Is there a role for antibiotics as primary therapy in Crohn’s ileitis? J Clin Gastroenterol 1993;17:235–7.
  • van Kruiningen HJ. On the use of antibiotics in Crohn’s disease. J Clin Gastroenterol 1995;20:310–6.
  • Wolf JL. Ciprofloxacin may be useful in Crohn’s disease. Gastroenterology 1990;98:A212.
  • Gui GP, Thomas PR, Tizard ML, Lake J, Sanderson JD, Hermon-Taylor J. Two-year-outcomes analysis of Crohn’s disease treated with rifabutin and macrolid antibiotics. J Antimicrob Chemother 1997;39:393–400.
  • Greenbloom SL, Steinhart AH, Greenberg GR. Combination ciprofloxacin and metronidazole for active Crohn’s disease. Can J Gastroenterol 1998;12:53–6.
  • Prantera MD, Zannoni F, Scribano ML, Berto E, Andreoli A, Kohn A, et al. An antibiotic regimen for the treatment of active Crohn’s disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am J Gastroenterol 1996;91:328–32.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.